Ara-290, AOD-9604, and SS-31: Three Compounds That Went Through Real Drug Development

Quick answer: All three were pharmaceutical programs, not community discoveries. One completed Phase 2 trials with positive results and then ran out of company. One failed its pivotal trial outright and was abandoned in 2007. One spent two decades missing endpoints and then won an FDA approval in 2025. Knowing which is which tells you […]